In a previous study, we used the same strategy for the integration of FANCA into patient‐derived fibroblasts that were subsequently reprogrammed and differentiated in vitro to generate disease‐free FA hematopoietic progenitors (Rio et al, 2014). This evidence concerns the gene FANCA and Friedreich ataxia.